TG Therapeutics (TGTX) News Today $57.40 +0.96 (+1.70%) Closing price 10/28/2026 04:00 PM EasternExtended Trading$56.01 -1.39 (-2.43%) As of 04:03 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share News and Trends Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest TG Therapeutics Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2026 September 2026 August 2026 July 2026 June 2026 May 2026 April 2026 March 2026 February 2026 January 2026 December 2025 November 2025 October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 Time Period More filters Fewer filters Done TG Therapeutics (TGTX) Stock May Be Underpriced Relative To EarningsOctober 28 at 4:17 AM | finance.yahoo.comAnalysts Offer Insights on Healthcare Companies: Elanco Animal Health (ELAN), IQVIA Holdings (IQV) and TG Therapeutics (TGTX)October 27 at 11:16 PM | theglobeandmail.comWhy TG Therapeutics (TGTX) Shares Climbed After Its Latest UpdateOctober 27 at 11:16 PM | finance.yahoo.comHow Investors Are Reacting To TG Therapeutics (TGTX) Early MS Cell Therapy DataOctober 27 at 6:15 PM | finance.yahoo.comTG Therapeutics: The Business Is More Attractive Than The ValuationOctober 27 at 9:17 AM | seekingalpha.comTG Therapeutics (NASDAQ:TGTX) Stock Breaks Above 50-Day Moving Average - Time to Sell?October 27 at 4:59 AM | marketbeat.comTG Therapeutics, Inc. (TGTX) - What Are Analysts Thinking About This Stock?October 27 at 3:17 AM | americanbankingnews.comTG Therapeutics (TGTX) Projected to Release Earnings on MondayOctober 26 at 4:57 AM | americanbankingnews.comTG Therapeutics (TGTX) Expected to Post Earnings on MondayOctober 26 at 4:55 AM | marketbeat.comTGTX stock bucks broader biotech selloff as multiple sclerosis therapy shows promising early results — here's what investors need to knowOctober 24, 2026 | msn.comTG Therapeutics, Inc. Announces Phase 1 Data Evaluating Azer-Cel in Progressive Multiple Sclerosis At MSToronto2026October 23, 2026 | marketscreener.comMTGTX stock bucks broader biotech selloff as multiple sclerosis therapy shows promising early results — here’s what investors need to knowOctober 23, 2026 | msn.comTG Therapeutics, Inc. $TGTX Stock: Assenagon Asset Management S.A. Cuts HoldingsOctober 23, 2026 | marketbeat.comTG Therapeutics, Inc. (NASDAQ:TGTX) Stock Has Average Target Price of $63.00 According to BrokeragesOctober 22, 2026 | marketbeat.comTG Therapeutics Highlights New Clinical Data Across Multiple Sclerosis Portfolio at MSToronto2026October 21, 2026 | finance.yahoo.comTG Therapeutics Announces Publication of Five-Year Comparative Analysis of BRIUMVI Versus Ocrelizumab and Ofatumumab in Relapsing Multiple SclerosisOctober 12, 2026 | businesswire.comTg Therapeutics, Inc. Announces Schedule of Data Presentations At Mstoronto2026October 9, 2026 | marketscreener.comMTG Therapeutics (TGTX) Stock May Be Undervalued Despite Fresh NewsflowOctober 9, 2026 | finance.yahoo.comTG Therapeutics (TGTX) Just Sparked A Bigger QuestionOctober 8, 2026 | finance.yahoo.comTG Therapeutics Announces Schedule of Data Presentations at MSToronto2026October 8, 2026 | businesswire.comTG Therapeutics (NASDAQ:TGTX) Raised to Hold at Zacks ResearchOctober 8, 2026 | marketbeat.comTG Therapeutics (NASDAQ:TGTX) Shares Break Above 200 Day Moving Average - Should You Sell?October 6, 2026 | marketbeat.comKuehn Law Encourages Investors of TG Therapeutics, Inc. to Contact Law FirmSeptember 28, 2026 | prnewswire.comTG Therapeutics Inc (TGTX)September 24, 2026 | ru.investing.comDow Jones futures fall after Nasdaq hits new high; SanDisk, Micron trigger buy signalsSeptember 23, 2026 | msn.comDow Jones futures: Nasdaq hits new high; SanDisk, Micron trigger buy signalsSeptember 22, 2026 | msn.comTG Therapeutics (TGTX) Could Be 19% Undervalued After Its Recent ReboundSeptember 18, 2026 | finance.yahoo.comTG Therapeutics (NASDAQ:TGTX) Director Sells 5,000 SharesSeptember 15, 2026 | insidertrades.comTG Therapeutics to Participate in H.C. Wainwright 28th Annual Global Investment ConferenceSeptember 10, 2026 | quiverquant.comQTG Therapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment ConferenceSeptember 10, 2026 | globenewswire.comTG Therapeutics to Participate in the Cantor Global Healthcare ConferenceSeptember 3, 2026 | globenewswire.comIBD stock of the day, TG Therapeutics, eyes breakout after topping early buy pointSeptember 2, 2026 | msn.comTGTX stock pares opening losses after analyst dismisses competition from NovartisSeptember 1, 2026 | msn.comTG Therapeutics: Briumvi's Peak May Be Far Away (Rating Upgrade)August 26, 2026 | seekingalpha.comTGTX stock outperforms 95% of stocks. Here's why.August 24, 2026 | msn.comTG Therapeutics: Briumvi's Growth Attracts Buyout RumorsAugust 22, 2026 | seekingalpha.comTGTX stock alert: What to know as takeover rumors swirl around TG TherapeuticsAugust 21, 2026 | msn.comTG Therapeutics (TGTX) Q2 2026 Earnings Call TranscriptAugust 11, 2026 | finance.yahoo.comTG Therapeutics : TGTXAugust 4, 2026 | 247wallst.comTG Therapeutics (TGTX) Is Down 15.9% After Q2 Miss But Raised 2026 Outlook - What's ChangedAugust 4, 2026 | finance.yahoo.comTG Therapeutics: Why I'm Staying Long After The Q2 SelloffAugust 3, 2026 | seekingalpha.comTG Therapeutics (TGTX) Q2 2026 EarningsAugust 3, 2026 | 247wallst.comTG Therapeutics Reports Second Quarter 2026 Financial Results and Raises BRIUMVI® Revenue GuidanceAugust 3, 2026 | uk.finance.yahoo.comThree noteworthy biotechs just reported earnings — and only one recoveredAugust 3, 2026 | msn.comTG Therapeutics CEO Says Briumvi Is On Track To Become A $1B US Drug – Retail Shrugs Off EPS MissAugust 3, 2026 | finance.yahoo.comTG Therapeutics raises 2026 outlook following strong Briumvi sales growthAugust 3, 2026 | msn.comTG Therapeutics, Inc. (TGTX) Q2 2026 Earnings Call TranscriptAugust 3, 2026 | seekingalpha.comTG Therapeutics Reports Second Quarter 2026 Financial Results and Raises BRIUMVI® Revenue GuidanceAugust 3, 2026 | globenewswire.comTG Therapeutics to Host Conference Call on Second Quarter 2026 Financial Results and Business UpdateJuly 29, 2026 | globenewswire.comKuehn Law Encourages Investors of TG Therapeutics, Inc. to Contact Law FirmJuly 21, 2026 | prnewswire.com TG Therapeutics Media Mentions By Week TG Therapeutics Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TGTX News Sentiment▼0.550.68▲Average Healthcare News Sentiment TG Therapeutics News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TGTX Articles This Week▼156▲TGTX Articles Average Week TG Therapeutics Trends on MarketBeatThis week vs. last weekNew Followers2-33%Searches1-80%Page Views3,188-10% Get TG Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TGTX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Alnylam Pharmaceuticals News Genmab A/S News Roivant Sciences News United Therapeutics News Incyte News BioNTech News Insmed News Exelixis News Ascendis Pharma A/S News Halozyme Therapeutics News News and Trends Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for TG Therapeutics dated 10/28/2026. From Our PartnersThe cash in your checking account has a problemThere's a pile of cash sitting in your checking account, earning next to nothing while you weigh your options....Counterflow | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | SponsoredA free stock pick, from me to youElon's paid this chip supplier since 2012. When NVIDIA tried to buy the company, he fought the deal. Withou...Behind the Markets | SponsoredManagement just bought 2.8 million sharesManagement just backed a $100 million buyback, repurchasing 2.8 million shares at an average price of $35.26 i...Monument Traders Alliance | SponsoredA Simple Guide to Options Trading While It's Still FreeA free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe cal...True Market Insiders | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredDon't lose access to thisIan Cooper's guide, 'The $50-to-$500 Options Strategy,' is still available for free download, but not for long...TradeWins | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TG Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TG Therapeutics With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
